124 related articles for article (PubMed ID: 11835998)
1. Dansyl-PQRamide, a possible neuropeptide FF receptor antagonist, induces conditioned place preference.
Huang EY; Li JY; Wong CH; Tan PP; Chen JC
Peptides; 2002 Mar; 23(3):489-96. PubMed ID: 11835998
[TBL] [Abstract][Full Text] [Related]
2. Modulation of naloxone-precipitated morphine withdrawal syndromes in rats by neuropeptide FF analogs.
Tan PP; Chen JC; Li JY; Liang KW; Wong CH; Huang EY
Peptides; 1999; 20(10):1211-7. PubMed ID: 10573293
[TBL] [Abstract][Full Text] [Related]
3. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
Kotlinska J; Pachuta A; Bochenski M; Silberring J
Peptides; 2009 Jun; 30(6):1165-72. PubMed ID: 19463751
[TBL] [Abstract][Full Text] [Related]
4. Neuropeptide FF (NPFF) reduces the expression of cocaine-induced conditioned place preference and cocaine-induced sensitization in animals.
Kotlinska J; Pachuta A; Silberring J
Peptides; 2008 Jun; 29(6):933-9. PubMed ID: 18295932
[TBL] [Abstract][Full Text] [Related]
5. Neuropeptide FF attenuates the acquisition and the expression of conditioned place aversion to endomorphin-2 in mice.
Han ZL; Wang ZL; Tang HZ; Li N; Fang Q; Li XH; Yang XL; Zhang XY; Wang R
Behav Brain Res; 2013 Jul; 248():51-6. PubMed ID: 23578757
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous injection of an analog of neuropeptide FF prevents naloxone-precipitated morphine abstinence syndrome.
Malin DH; Lake JR; Smith DA; Jones JA; Morel J; Claunch AE; Stevens PA; Payza K; Ho KK; Liu J
Drug Alcohol Depend; 1995 Nov; 40(1):37-42. PubMed ID: 8746922
[TBL] [Abstract][Full Text] [Related]
7. Neuropeptide FF (NPFF) reduces the expression of morphine- but not of ethanol-induced conditioned place preference in rats.
Kotlinska J; Pachuta A; Dylag T; Silberring J
Peptides; 2007 Nov; 28(11):2235-42. PubMed ID: 17884254
[TBL] [Abstract][Full Text] [Related]
8. Modulation of neuropeptide FF (NPFF) receptors influences the expression of amphetamine-induced conditioned place preference and amphetamine withdrawal anxiety-like behavior in rats.
Kotlinska JH; Gibula-Bruzda E; Koltunowska D; Raoof H; Suder P; Silberring J
Peptides; 2012 Jan; 33(1):156-63. PubMed ID: 22197492
[TBL] [Abstract][Full Text] [Related]
9. Distribution of neuropeptide FF (NPFF) receptors in correlation with morphine-induced reward in the rat brain.
Wu CH; Tao PL; Huang EY
Peptides; 2010 Jul; 31(7):1374-82. PubMed ID: 20381562
[TBL] [Abstract][Full Text] [Related]
10. Dexmedetomidine induces conditioned place preference in rats: Involvement of opioid receptors.
Uskur T; Barlas MA; Akkan AG; Shahzadi A; Uzbay T
Behav Brain Res; 2016 Jan; 296():163-168. PubMed ID: 26376284
[TBL] [Abstract][Full Text] [Related]
11. The influence of a new derivate of kisspeptin-10 - Kissorphin (KSO) on the rewarding effects of morphine in the conditioned place preference (CPP) test in male rats.
Gibula-Tarlowska E; Kedzierska E; Piechura K; Silberring J; Kotlinska JH
Behav Brain Res; 2019 Oct; 372():112043. PubMed ID: 31226311
[TBL] [Abstract][Full Text] [Related]
12. Morphine sex-dependently induced place conditioning in adult Wistar rats.
Karami M; Zarrindast MR
Eur J Pharmacol; 2008 Mar; 582(1-3):78-87. PubMed ID: 18191832
[TBL] [Abstract][Full Text] [Related]
13. Synaptic actions of neuropeptide FF in the rat parabrachial nucleus: interactions with opioid receptors.
Chen X; Zidichouski JA; Harris KH; Jhamandas JH
J Neurophysiol; 2000 Aug; 84(2):744-51. PubMed ID: 10938301
[TBL] [Abstract][Full Text] [Related]
14. Glycyl-glutamine, an endogenous beta-endorphin-derived peptide, inhibits morphine-induced conditioned place preference, tolerance, dependence, and withdrawal.
Cavun S; Göktalay G; Millington WR
J Pharmacol Exp Ther; 2005 Nov; 315(2):949-58. PubMed ID: 16079299
[TBL] [Abstract][Full Text] [Related]
15. Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatments.
Elhabazi K; Trigo JM; Mollereau C; Moulédous L; Zajac JM; Bihel F; Schmitt M; Bourguignon JJ; Meziane H; Petit-demoulière B; Bockel F; Maldonado R; Simonin F
Br J Pharmacol; 2012 Jan; 165(2):424-35. PubMed ID: 21718302
[TBL] [Abstract][Full Text] [Related]
16. Buprenorphine and a CRF1 antagonist block the acquisition of opiate withdrawal-induced conditioned place aversion in rats.
Stinus L; Cador M; Zorrilla EP; Koob GF
Neuropsychopharmacology; 2005 Jan; 30(1):90-8. PubMed ID: 15138444
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous activation of spinal antiopioid system (neuropeptide FF) and pain facilitatory circuitry by stimulation of opioid receptors in rats.
Devillers JP; Boisserie F; Laulin JP; Larcher A; Simonnet G
Brain Res; 1995 Nov; 700(1-2):173-81. PubMed ID: 8624708
[TBL] [Abstract][Full Text] [Related]
18. Central administration of neuropeptide FF and related peptides attenuate systemic morphine analgesia in mice.
Fang Q; Jiang TN; Li N; Han ZL; Wang R
Protein Pept Lett; 2011 Apr; 18(4):403-9. PubMed ID: 21121889
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide FF receptors antagonist, RF9, attenuates opioid-evoked hypothermia in mice.
Wang YQ; Guo J; Wang SB; Fang Q; He F; Wang R
Peptides; 2008 Jul; 29(7):1183-90. PubMed ID: 18406009
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological effects of the dansylated neuropeptide FF analogues on body temperature and morphine analgesia.
Fang Q; He F; Wang YQ; Guo J; Zhang BZ; Chen Q; Wang R
Neuropeptides; 2007 Oct; 41(5):339-47. PubMed ID: 17597204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
